What is the maximum recommended dose of trazodone for treating insomnia in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Maximum Dose of Trazodone for Sleep

The American Academy of Sleep Medicine (AASM) recommends AGAINST using trazodone for insomnia treatment, and when studied, only 50 mg doses were evaluated—this is effectively the evidence-based maximum for sleep purposes. 1

Critical Guideline Recommendation

The 2017 AASM Clinical Practice Guideline explicitly states: "We suggest that clinicians not use trazodone as a treatment for sleep onset or sleep maintenance insomnia (versus no treatment) in adults." This weak recommendation against use is based on trials using 50 mg doses that failed to demonstrate clinically significant improvements in sleep outcomes. 1

Why This Matters

The single high-quality study meeting AASM inclusion criteria (Walsh et al.) evaluated trazodone 50 mg and found:

  • Sleep latency reduced by only 10.2 minutes (below clinical significance threshold)
  • Total sleep time increased by only 21.8 minutes (clinically insignificant)
  • Wake after sleep onset reduced by only 7.7 minutes (below threshold)
  • 75% of patients experienced adverse events (vs. 65.4% with placebo), including headache (30%) and somnolence (23%) 1

Real-World Dosing Context

Despite the AASM recommendation against use, trazodone remains widely prescribed off-label for insomnia. When clinicians do use it:

Typical Dosing Range for Sleep

  • Starting dose: 25-50 mg at bedtime
  • Common effective range: 50-100 mg 2
  • Studied maximum for sleep: 50 mg in the guideline-quality evidence 1
  • Antidepressant doses: 150-300 mg (but this is for depression, not insomnia) 3

Important Caveats

The FDA has NOT approved trazodone for insomnia—it is only approved for major depressive disorder. The maximum recommended human dose (MRHD) for depression is 400 mg/day in adults. 4 However, this depression dosing should not be extrapolated to insomnia treatment.

Research studies in depression patients with comorbid sleep problems have used:

  • 25-100 mg for sleep effects 5
  • 50-150 mg in opioid-dependent patients (mean effective dose 101.9 mg) 6
  • Single nighttime doses of 100-400 mg in depression trials 7, 8

Clinical Decision Algorithm

If considering trazodone despite guideline recommendations:

  1. Start at 25-50 mg at bedtime (lower dose for elderly, those on other CNS depressants)

  2. Maximum for sleep purposes: 100 mg based on research evidence showing efficacy at this dose 2

  3. Do not exceed 150 mg for insomnia alone without treating comorbid depression

  4. Monitor closely for:

    • Next-day cognitive impairment (memory, verbal learning deficits documented even at 50 mg) 9
    • Somnolence and sedation
    • Orthostatic hypotension (especially in elderly)
    • Priapism (rare but serious)
  5. Reassess after 7-10 days—if insomnia persists, consider alternative evidence-based treatments rather than dose escalation

Preferred Alternatives

The AASM guideline recommends these agents OVER trazodone for insomnia:

  • Doxepin 3-6 mg for sleep maintenance
  • Zolpidem 10 mg for sleep onset and maintenance
  • Eszopiclone 2-3 mg for sleep onset and maintenance
  • Suvorexant for sleep maintenance 1

The American College of Physicians (2016) similarly found insufficient evidence for trazodone while supporting other agents. 10

Bottom Line

While no formal "maximum dose for sleep" exists in guidelines, the evidence-based ceiling is 50-100 mg. Doses above 100 mg for insomnia alone lack supporting evidence and increase adverse effects without proven additional benefit. The strongest recommendation is to avoid trazodone for insomnia entirely and use guideline-supported alternatives with better efficacy and safety profiles.

References

Guideline

clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an american academy of sleep medicine clinical practice guideline.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2017

Research

Trazodone: alternative dose regimens and sleep.

Pharmatherapeutica, 1984

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.